Frontal lobe growth is impaired in fetuses with congenital heart disease

D Paladini1, A Finarelli1, G Donarini1

  • 1Fetal Medicine and Surgery Unit, Istituto G. Gaslini, Genoa, Italy.

Insights

Fetuses with congenital heart disease (CHD) show smaller frontal brain areas and a reduced frontal-to-occipital-frontal diameter ratio compared to healthy fetuses. This brain development difference is observed across all CHD types.

Area of Science:

  • Fetal Medicine
  • Pediatric Cardiology
  • Neurodevelopmental Pediatrics

Background:

  • Congenital heart disease (CHD) affects fetal development.
  • The impact of CHD on fetal brain structure, specifically frontal lobe development, requires further investigation.

Purpose of the Study:

  • To compare frontal brain areas in fetuses with CHD versus normal controls.
  • To analyze frontal brain area differences among various CHD subtypes based on hemodynamic impact.

Main Methods:

  • Retrospective cross-sectional study of 421 normal and 101 CHD fetuses (20-39 weeks gestation).
  • Measurement of frontal lobe anteroposterior diameter (FAPD) and occipitofrontal diameter (OFD) using transventricular axial view.
  • Calculation of FAPD/OFD ratio and comparison between groups, with adjustments for gestational age.

Main Results:

  • Fetuses with CHD exhibited a shorter FAPD and a significantly smaller FAPD/OFD ratio compared to normal fetuses (P < 0.0001).
  • These differences were evident from 20 weeks gestation and increased after 30 weeks.
  • No significant differences in the FAPD/OFD ratio were found among different CHD categories.

Conclusions:

  • Fetuses with CHD demonstrate reduced frontal brain area growth compared to controls.
  • Impaired frontal lobe development in CHD appears independent of the specific hemodynamic impact of the defect.
Abstract

Related Concept Videos

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
1.8K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
2.1K
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
44.7K